SOCS1 was initially thought to be a potent inhibitor of the JAK-STAT pathway, which not only has a negative role in downregulating JAK signaling, but can also modulate other signaling pathways that can stimulate STAT activation, and is involved in the progression of various cancers [41,42]. The gene discussed is SOCS1; the disease is cancer.